Women With Severe Maternal Morbidity Less Likely to Have Subsequent Birth
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 25, 2024 -- Women who experience severe maternal morbidity (SMM) in the first birth are less likely to have a subsequent birth, according to a study published online Nov. 25 in the Journal of the American Medical Association.
Eleni Tsamantioti, M.D., from the Karolinska Institutet in Stockholm, and colleagues examined the association between SMM in a first birth and the probability of a subsequent birth in a retrospective, population-based cohort study conducted among 1,046,974 women in Sweden with a first birth between 1999 and 2021.
Overall, 3.5 percent of women experienced an SMM condition in their first birth. The researchers found that women with any SMM versus those without SMM in their first delivery had a reduced incidence rate of subsequent birth (136.6 versus 182.4 per 1,000 person-years; adjusted hazard ratio, 0.88). Women with severe uterine rupture, cardiac complications, cerebrovascular accident, and severe mental health conditions had a substantially lower probability of subsequent birth (adjusted hazard ratios, 0.48, 0.49, 0.60, and 0.48, respectively). Familial confounding did not influence the associations, as indicated in sibling analyses.
"Adequate reproductive counseling and improved monitoring and antenatal care are crucial for women with a history of SMM," the authors write.
One author disclosed ties to the Aixial Group.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-26 06:00
Read more
- Female Pediatricians Earn About 93 Percent of Male Pediatricians
- UroGen Announces FDA Acceptance of its New Drug Application for UGN-102
- Researchers Uncover New Role of Mutant Proteins in Some of the Deadliest Cancers
- Fasting at Night May Aid Glucose Metabolism in Night-Shift Workers
- Poor Sleep Quality Linked to Incident Motoric Cognitive Risk Syndrome
- Malaria Developing Resistance to Drug That Saves Children's Lives
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions